Moore to carry on at Pools despite cancer diagnosis
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
42 minutes ago
- The Independent
Warning issued to patients after using weight-loss jabs
Health chiefs have raised concerns about patients regaining weight after stopping popular weight-loss drugs such as Wegovy and Mounjaro, calling for robust support to prevent them from piling on the pounds again. The National Institute for Health and Care Excellence (Nice), the UK's health watchdog, highlighted research indicating that many individuals regain weight if not adequately supported after ceasing treatment. Nice stressed that those coming off the drugs should be offered "structured advice and follow-up support" to mitigate weight gain. This guidance specifically applies to individuals receiving these treatments through the NHS. However, an estimated 1.5 million people in the UK are currently using weight-loss injections, with the vast majority paying privately. These individuals will not be eligible for NHS support once their treatment concludes. Over the next three years, approximately 240,000 people deemed to have the "greatest need" are anticipated to receive Mounjaro, also known as tirzepatide, via the NHS. The new 'quality standard' from Nice says that NHS patients should be monitored for at least a year after they complete treatment, and extra support should be offered if needed. It emphasises building 'long-term behavioural habits, use self-monitoring tools, and draw on wider support – from online communities to family-led interventions and local activities'. This standard, a type of guidance for the health services in England and Wales, sets out expectations for health providers including how they should support patients. 'Successful weight management doesn't end when medication stops or when someone completes a behavioural programme,' said Professor Jonathan Benger, deputy chief executive and chief medical officer at Nice. 'We know that the transition period after treatment is crucial, and people need structured support to maintain the positive changes they've made. 'This new standard makes sure services provide that vital continuity of care, and it supports the NHS 10 Year Plan to shift from a 'sickness service' to a genuine health service focused on prevention.' Dr Rebecca Payne, chair of Nice's Quality Standards Advisory Committee, added: 'Weight management is a long-term journey, not a short-term fix. 'The evidence is clear that advice and support for maintaining weight after stopping medicines or completing behavioural interventions can help prevent weight regain and enable people to experience lasting benefits. 'We've seen excellent examples of services that already provide comprehensive discharge planning and ongoing support. 'This quality standard will help ensure all healthcare providers adopt these best practices, giving every person the best chance of maintaining their weight management success over the long term. 'This standard ensures healthcare services are equipped to provide that essential ongoing support.' Commenting, Henry Gregg, chief executive of the National Pharmacy Association, said: ' Pharmacies take their responsibilities seriously to provide full wrap around support to patients trying to achieve a healthy weight. 'We know that although medication can be effective in speeding up weight loss in some people, it is not a silver bullet and patients need to make long term lifestyle changes to make their weight loss sustainable. 'The current NHS roll out of weight loss treatment is very small, with only a handful of patients receiving it and it will continue to be the case that the vast majority of eligible patients will be seen by their pharmacy.' Professor Kamila Hawthorne, chairwoman of the Royal College of GPs, said: 'There is no one-size-fits-all approach to tackling obesity – what works for one patient will likely not work for another and, as with any medication, weight-loss drugs do not come without risk. 'It's also the case that patients will likely need support to sustain their weight loss once they stop taking the medication. As such, this is important and sensible guidance from Nice. 'As a college, we've been clear that whilst weight loss medications have significant potential benefits for patients who are struggling to lose weight, they mustn't be seen as a 'silver bullet' and ensuring access to sufficient 'wraparound' services – particularly for when patients come off their medication – will be key to optimal health outcomes.'
The Independent
42 minutes ago
- The Independent
Urgent warning over virus dangerous to newborns as cases surge abroad
Health experts say the UK should brace for a surge in a potentially serious virus following a record number of cases in Australia. NHS officials said that the Australian winter is often a good predictor of how viruses will spread in England. In Australia, respiratory syncytial virus (RSV) cases have surged in recent months, and officials have said that cases have been steadily increasing in England since the start of 2025. NHS England has urged pregnant women to get the vaccine, which protects against RSV, in order to protect their newborn babies. The virus is a leading cause of death among babies and the main cause of hospital admissions for children. Kate Brintworth, chief midwifery officer for NHS England, said that while for most adults, RSV 'only causes mild, cold-like symptoms, for older adults and young children, it can lead to serious breathing problems that can end up in hospitalisation'. 'Getting vaccinated while pregnant is the best way to protect your baby from the moment they are born, and now is the time for mums to act, to make sure their babies are protected ahead of their first few months this winter, when there tends to be more bugs circulating.' Pregnant women can get the jab from 28 weeks of pregnancy onwards through their maternity services or GP surgery. Older adults aged 75-79 are also eligible for the jab, and NHS England will start inviting people to come forward in the next few weeks. Symptoms of an RSV infection NHS RSV is a common cause of coughs and colds, but some people have a high risk of getting seriously ill from the virus, including babies and adults over the age of 75. In babies, RSV is a common cause of a type of chest infection called bronchiolitis. Last week, the UK Health Security Agency published data showing the efficacy of the vaccine. It said that the jab for pregnant women can prevent 72 per cent of hospital admissions for their babies. And the vaccine is 82 per cent effective at preventing hospital admissions for RSV among older adults, UKHSA said.
Daily Mail
43 minutes ago
- Daily Mail
Liverpool's new £79m striker Hugo Ekitike reveals why he joined the Premier League champions and issues warning to their title rivals after impressive Anfield debut
Hugo Ekitike has opened up on his decision to join Liverpool in a £79million deal and issued a warning to their Premier League title rivals after impressing in his first appearance at Anfield. The Frenchman was part of the Reds squad that contested the second of two matches against LaLiga side Athletic Bilbao on Monday, assisting the side's opener in a 3-2 win, following a 4-1 victory for the less experienced roster hours earlier. Ekitike was one of five new signings to feature for Arne Slot 's free-spending side, who were playing in their first home match since the tragic death of forward Diogo Jota, as the Premier League champions put the finishing touches on their preparations for the new campaign. Liverpool saw off competition from the likes of Newcastle and Manchester United to secure the 23-year-old's signature and after making a great first impression in front of the home support, Ekitike claimed that made the switch from Eintracht Frankfurt 'to win'. 'We have a group of competitors,' he told LFCTV. 'We want to win everything. We are going to give 100 per cent. I am going to give 100 per cent. I am here to win.' The young forward linked up well with his new team-mates despite Monday's clash being only the second time he has turned out alongside them. The France Under 21 international hailed his new colleagues, adding: 'I enjoy playing with them. 'Outside of the pitch they are good guys. We have some little things to fix, on the ball. I have things I can do better. I am going to enjoy playing with them for the season.' Ekitike's acquisition is the most recent by Liverpool this summer but it is unlikely to be their last piece of business before the window closes at the start of next month. Darwin Nunez, who scored in the first match at Anfield, has been heavily linked with a move away this summer and is attracting interest from AC Milan and Saudi Pro League side Al Hilal. Meanwhile, the Reds are eyeing an audacious move for Newcastle United star Alexander Isak and saw an opening £110m bid rejected on Friday. The Reds are next in action in the Community Shield, where they will face FA Cup winners Crystal Palace at Wembley. They begin the defence of their Premier League title at home against Bournemouth on August 15.
